Skip to main content
TipRanks
Go Ultimate75% OFF

Merdury Biopharmaceutical Corporation (6932) Balance Sheet

Merdury Biopharmaceutical Corporation Balance Sheet

Merdury Biopharmaceutical Corporation's total assets for Q2 2026 were NT$259.89M, a decrease of 6.64% from the previous quarter. TW:6932 total liabilities were NT$59.12M for the fiscal quarter, a 0.68% an increase from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Dec 23Dec 22Dec 21
NT$ 278.39MNT$ 353.20MNT$ 438.07MNT$ 229.93MNT$ 13.38M
NT$ 58.72MNT$ 62.93MNT$ 49.72MNT$ 49.60MNT$ 2.92M
NT$ 219.67MNT$ 290.27MNT$ 388.35MNT$ 180.33MNT$ 10.46M

Currency in TWD

Merdury Biopharmaceutical Corporation Liabilities to Assets

0200M400M600M0 %120 %240 %360 %LiabilitiesLiabilities to Assets2019202020212022202320242025AssetsLiabilitiesLiabilities to Assets